Compounded GLP-1 Safety: What the FDA Says in 2026
Compounded GLP-1 medications have made weight loss treatment affordable for millions of Americans. But they exist in a regulatory gray area that patients need to understand before enrolling with any provider.
What "compounded" actually means
Compounding is the process of a licensed pharmacy preparing a customized medication using FDA-approved active pharmaceutical ingredients. For GLP-1s, this means a compounding pharmacy creates semaglutide or tirzepatide formulations that contain the same active ingredient as Wegovy, Ozempic, Mounjaro, or Zepbound — but the finished product itself is not FDA-approved.
Compounding has been a legitimate part of pharmacy practice for decades, primarily used when a patient needs a dose, format, or formulation not commercially available. The explosion of compounded GLP-1s is driven by the massive cost gap between brand-name medications ($1,000+/month) and compounded versions ($99–$300/month).
503A vs 503B pharmacies
503A pharmacies are state-regulated and prepare medications on a patient-specific prescription basis. This is the standard for most compounded GLP-1 telehealth platforms, including GobyMeds. Each prescription is individually compounded for a specific patient.
503B pharmacies are FDA-registered "outsourcing facilities" that can produce larger batches without patient-specific prescriptions. They face more stringent FDA oversight, including regular inspections. Some providers, including GobyMeds, work with both 503A and 503B partners.
The FDA's position
The FDA has consistently stated that compounded medications are not FDA-approved and has not individually reviewed them for safety, effectiveness, or quality. In March 2026, the FDA issued warning letters to 30 telehealth companies for misleading marketing claims about compounded GLP-1s — part of a broader enforcement wave that has sent thousands of warnings since September 2025.
However, the FDA has not banned compounded GLP-1s. The agency's primary concern is misleading marketing (claiming compounded medications are "the same as" brand-name drugs or making unsubstantiated efficacy claims), not the practice of compounding itself.
How to verify your provider
✅ Check for LegitScript certification
LegitScript independently verifies telehealth platforms across 11 compliance standards. It's required for advertising on Google and Meta, and for Visa/Mastercard payment processing.
✅ Ask about pharmacy partners
Legitimate providers will disclose whether they use 503A, 503B, or both pharmacy types. You can verify pharmacy licenses through your state board of pharmacy.
✅ Look for clinical oversight
Providers using established clinical networks like OpenLoop Health (used by Sunlight and MEDVi) have an additional layer of medical oversight through licensed physician groups.
⚕️ FDA Notice: Compounded medications are not FDA-approved. They are prepared by licensed compounding pharmacies using FDA-approved active ingredients but are not individually reviewed by the FDA for safety, effectiveness, or quality. Always consult a licensed clinician before starting any GLP-1 therapy.
Our perspective
Compounded GLP-1s represent a pragmatic solution to a pricing problem. When brand-name medications cost $1,000+/month and insurance coverage is inconsistent, compounded alternatives from verified providers make treatment accessible. The key is choosing providers with strong third-party verification — LegitScript certification being the most meaningful credential — and understanding that compounded medications carry different regulatory assurances than brand-name products.
GobyMedsLegitScript ✅
LegitScript certified. 503A + 503B pharmacy partners. Don't pay until approved. Code x7X72r saves $25.